KI Investment Holdings, LLC: An Investment in Long-Term Principles KI Investment Holdings, LLC: An Investment in Long-Term Principles
KI Investment Holdings, LLC: Site Map KI Investment Holdings, LLC: Investor Login KI Investment Holdings, LLC: Event Calendar KI Investment Holdings, LLC: News and Newsletter Archives KI Investment Holdings, LLC: Resource and Docment Library
About KI Investment Holdings, LLC Contact KI Investment Holdings, LLC KI Investment Holdings, LLC: Learn How to Apply for Financing Become a KI Investment Holdings, LLC Investor
Anita I. Busquets, M.B.A. CFO, KI Investment Holdings, LLC
Anita I. Busquets, M.B.A. is a highly experienced, start-up executive who has served in a wide range of operating and financial management roles. Ms. Busquets serves as the CFO of KI Investment Holdings, LLC.

Ms. Busquets is the co-owner of Aliane Wines, a San Diego based wine importer and distributor of fine wines produced by small independent family owned vintners. She also serves as President and COO of NCE Pharmaceuticals, Inc., a small agricultural biotech company focused on antifungal and antibacterial compounds and technologies. Prior to that, Ms. Busquets served as Chief Financial and Administrative Officer of then-startup Salmedix, Inc., a San Diego based drug development company. At Salmedix, she was responsible for all aspects of administration including finance, accounting, human resources, information technology and facilities. She, along with the executive team, was responsible for all corporate strategy, business planning, obtaining funding and implementation of the plans. She successfully assisted the CEO in raising $82.6 million in less than four years, filed an S-1 registration statement with the SEC to go public and ultimately sold the company to Cephalon, Inc. for $200 million in cash and milestones. The milestone payments were achieved.

Prior to joining Salmedix, she managed Biotechnology Management Consultants and co-founded and served as President of GeneTex, Inc. Genetex was sold to a Taiwanese firm for cash at the beginning of 2011. Earlier she served as the Chief Operating Officer at the CTRC Research Foundation, a subsidiary of the Cancer Therapy and Research Center in San Antonio where she was instrumental in incubating and spinning out Ilex Oncology, which was acquired by Genzyme for $1 billion in 2004. Genzyme was recently acqired by Sanofi Aventis Pharmaceuticals. Earlier in her career, Ms. Busquets served as Director of Finance and Administration of Corvas International, Inc. Ms. Busquets holds a B.S. from Cornell University and an M.B.A. from Simmons College Graduate School of Management in Boston.

Ms. Busquets serves on three boards including, NCE Pharmaceuticals, Inc., Athena San Diego and San Diego Natural History Museum. She serves as Chair of the Audit Committee for Planned Parenthood of the Pacific Southwest. In the past she served as a director of Project Wildlife, Chairman of the Board of VNA and Hospice of South Texas and as President of the KLRN (local PBS station) Community Advisory Board, in addition to the board of GeneTex, Inc. in San Antonio, Texas. She is an active Member of Run Women Run and serves on its Advisory Board.
© 2011 KI Investment Holdings, LLC
Home      Investor Login      Event Calendar      News      Resources      Site Map      About Us      Contact Us
Learn How to Apply for Financing      Become an Investor

Website Development by Britt Development

Staff Login